Rare disease

Small cell lung cancer extensive stage

31 clinical trials

Quick filters

Clinical trials for Small cell lung cancer extensive stage

31 trials across Europe

See all trials →

Quick filters

31 Clinical trials

Small cell lung cancer+2

Recruiting

Registered drugNo placebo

Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:BioNTech SE

Contact Research Centre

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

Phase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Siltuximab
Sponsor:Amgen Inc.

Contact Research Centre

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

Study of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients

Registered drugNo placebo

France

Participants:18–64 years
Substances:Atezolizumab
Sponsor:Merck Sharp & Dohme LLC

Contact Research Centre

Lung neoplasm malignant+2

Recruiting

InvestigationalNo placebo

A study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Tarlatamab
Sponsor:ETOP IBCSG Partners Foundation

Contact Research Centre

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

A study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Pfizer Inc.

Contact Research Centre

Small cell lung cancer extensive stage

Recruiting

Registered drugNo placebo

Study Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Topotecan
Sponsor:Gilead Sciences Inc.

Contact Research Centre

See all trials →

Small cell lung cancer extensive stage

Clinical trials for Small cell lung cancer extensive stage

Small cell lung cancer+2

Study of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer

Small cell lung cancer extensive stage

Phase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy

Small cell lung cancer extensive stage

Study of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients

Lung neoplasm malignant+2

A study to evaluate the effectiveness of tarlatamab in patients with extensive-stage small cell lung cancer that has progressed after prior treatment and who have limited health status

Small cell lung cancer extensive stage

A study of PF-08634404 and a drug combination for adult patients with extensive-stage small cell lung cancer

Small cell lung cancer extensive stage

Study Comparing Sacituzumab Govitecan and Standard Treatment for Patients with Previously Treated Extensive Stage Small Cell Lung Cancer

Filter the trials

Prefer not to search? Our Concierge searches the trials for you.